Heterogeneity of anti-β2-glycoprotein I antibodies
暂无分享,去创建一个
Y. Shoenfeld | M. Blank | M. Alessi | F. Dignat-George | N. Bardin | V. Pascal | J. Harle | M. Sanmarco
[1] J. Piette,et al. Prevalence and Clinical Correlations of Antibodies Against Six β2-Glycoprotein-I-Related Peptides in the Antiphospholipid Syndrome , 2003, Journal of Clinical Immunology.
[2] T. Barbui,et al. Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. , 2003, Blood.
[3] T. Kveder,et al. Inter-laboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group. , 2002, Thrombosis and haemostasis.
[4] T. Barbui,et al. Anti-beta2-glycoprotein I and anti-prothrombin antibodies in antiphospholipid-negative patients with thrombosis: a case control study. , 2002, Thrombosis and haemostasis.
[5] P. McNeeley,et al. Beta2-glycoprotein I-dependent anticardiolipin antibodies preferentially bind the amino terminal domain of beta2-glycoprotein I. , 2001, Thrombosis and haemostasis.
[6] I. Bruce,et al. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review. , 2000, The Journal of rheumatology.
[7] J. Gris,et al. Antiphospholipid and Antiprotein Syndromes in Non-thrombotic, Non-autoimmune Women with Unexplained Recurrent Primary Early Foetal Loss , 2000, Thrombosis and Haemostasis.
[8] T. Koike,et al. Beta 2-glycoprotein I-anti-beta 2-glycoprotein I interaction. , 2000, Journal of autoimmunity.
[9] W. Kutteh,et al. beta2-Glycoprotein 1 as a marker of antiphospholipid syndrome in women with recurrent pregnancy loss. , 2000, Fertility and sterility.
[10] R. Ravelli,et al. Adhesion mechanism of human β2‐glycoprotein I to phospholipids based on its crystal structure , 1999, The EMBO journal.
[11] W A Wilson,et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. , 1999, Arthritis and rheumatism.
[12] P. Hogg,et al. Microheterogeneity of beta-2 glycoprotein I: implications for binding to anionic phospholipids. , 1999, The Biochemical journal.
[13] E. Katchalski‐Katzir,et al. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[14] T. Byers,et al. Association of antibodies to beta2-glycoprotein 1 with pregnancy loss and pregnancy-induced hypertension: a prospective study in low-risk pregnancy. , 1999, Obstetrics and gynecology.
[15] P. Prandoni,et al. Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism. , 1999, Thrombosis research.
[16] L. Carreras,et al. Binding properties of antibodies to prothrombin and beta2-glycoprotein I (beta2-GPI) assayed by ELISA and dot blot. , 1999, Clinical and experimental immunology.
[17] K. Diederichs,et al. Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. , 1999, The EMBO journal.
[18] J. Reveille,et al. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. , 1998, The Journal of rheumatology.
[19] G. M. Iverson,et al. Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[20] P. Genton,et al. Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy. , 1997, The American journal of medicine.
[21] V. Debari,et al. The association of antibodies to beta 2 glycoprotein I with the antiphospholipid syndrome: a meta-analysis. , 1997, Annals of clinical and laboratory science.
[22] A. Tincani,et al. The anti-beta2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species' evolution. , 1996, Journal of immunology.
[23] D. Alarcón-Segovia,et al. The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays. , 1996, The American journal of medicine.
[24] M. Igarashi,et al. Human beta2-glycoprotein I as an anticardiolipin cofactor determined using mutants expressed by a baculovirus system. , 1996, Blood.
[25] D. Alarcón-Segovia,et al. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. , 1995, The Journal of rheumatology.
[26] R. Eisenberg,et al. "Anticardiolipin" autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. , 1995, Journal of immunology.
[27] T. Yasuda,et al. Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface , 1994, The Journal of experimental medicine.
[28] B. Roussel,et al. IgG2 subclass restriction of anti‐β2 glycoprotein 1 antibodies in autoimmune patients , 1994, Clinical and experimental immunology.
[29] S. Krilis,et al. Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[30] G. Hughes,et al. The “Primary” Antiphospholipid Syndrome: Major Clinical and Serological Features , 1989, Medicine.
[31] J. Sánchez-Guerrero,et al. Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients , 1989, Medicine.
[32] T. Kenner,et al. Characterization of isoelectric subspecies of asialo-beta 2-glycoprotein I. , 1989, The Biochemical journal.
[33] F. Putnam,et al. Complete amino acid sequence of human plasma beta 2-glycoprotein I. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[34] I. Schousboe. Characterization of subfractions of beta 2-glycoprotein I: evidence for sialic acid microheterogeneity. , 1983, The International journal of biochemistry.